Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to UY27102ApriorityCriticalpatent/UY27102A1/en
Publication of UY27102A1publicationCriticalpatent/UY27102A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a una forma sustancialmente cristalina de EtO2C-CH2-(R)Cgl-Aze-Pab-OH que se encuentra en forma de anhidrato, a composiciones farmacéuticas que la contienen y a procesos para obtener las mismas.The present invention relates to a substantially crystalline form of EtO2C-CH2- (R) Cgl-Aze-Pab-OH which is in the form of anhydrate, to pharmaceutical compositions containing it and to processes for obtaining them.
New crystal forms of atorvastatin hemicalcium and processes for their preparation, as well as new processes for the preparation of atorvastatin hemicalcium forms I, VIII and IX